As of 2026-03-07, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (9.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.86 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -166.8%.
The range of the Relative Valuation is (11.63) - (9.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.1x - 35.5x | 32.7x |
| Forward P/E multiples | 15.6x - 25.6x | 18.6x |
| Fair Price | (11.63) - (9.92) | (9.92) |
| Upside | -178.3% - -166.8% | -166.8% |
| Date | P/E |
| 2026-03-03 | -41.56 |
| 2026-03-02 | -41.66 |
| 2026-02-27 | -41.40 |
| 2026-02-26 | -42.54 |
| 2026-02-25 | -41.90 |
| 2026-02-24 | -41.48 |
| 2026-02-23 | -39.78 |
| 2026-02-20 | -39.29 |
| 2026-02-19 | -41.48 |
| 2026-02-18 | -41.02 |
| 2026-02-17 | -40.81 |
| 2026-02-13 | -41.46 |
| 2026-02-12 | -40.16 |
| 2026-02-11 | -40.37 |
| 2026-02-10 | -40.42 |
| 2026-02-09 | -40.99 |
| 2026-02-06 | -40.76 |
| 2026-02-05 | -42.57 |
| 2026-02-04 | -44.71 |
| 2026-02-03 | -47.81 |
| 2026-02-02 | -47.53 |
| 2026-01-30 | -47.81 |
| 2026-01-29 | -47.48 |
| 2026-01-28 | -47.81 |
| 2026-01-27 | -49.70 |
| 2026-01-26 | -49.42 |
| 2026-01-23 | -47.94 |
| 2026-01-22 | -49.26 |
| 2026-01-21 | -45.41 |
| 2026-01-20 | -46.19 |
| 2026-01-16 | -45.28 |
| 2026-01-15 | -45.95 |
| 2026-01-14 | -46.63 |
| 2026-01-13 | -46.70 |
| 2026-01-12 | -47.19 |
| 2026-01-09 | -40.73 |
| 2026-01-08 | -41.25 |
| 2026-01-07 | -43.24 |
| 2026-01-06 | -41.64 |
| 2026-01-05 | -41.79 |
| 2026-01-02 | -41.12 |
| 2025-12-31 | -41.97 |
| 2025-12-30 | -42.44 |
| 2025-12-29 | -43.03 |
| 2025-12-26 | -43.16 |
| 2025-12-24 | -43.11 |
| 2025-12-23 | -43.29 |
| 2025-12-22 | -45.00 |
| 2025-12-19 | -43.94 |
| 2025-12-18 | -42.65 |